Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The Development and Maintenance of Paclitaxel-Induced Neuropathic Pain Requires Activation of the Sphingosine 1-Phosphate Receptor Subtype 1.
Placebo power.
Targeting NOX enzymes in the central nervous system: therapeutic opportunities.
Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis.
Towards a Classification Approach using Meta-Biclustering: Impact of Discretization in the Analysis of Expression Time Series.
Diffusion-weighted imaging characteristics of biopsy-proven demyelinating brain lesions.
Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial.
Central nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic review of scientific production.
Factors related to difficulties with employment in patients with multiple sclerosis: a review of 2002-2011 literature.
Neuromyelitis optica in patients with coexisting human immunodeficiency virus infections.
Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis.
A Mushroom Extract Piwep from Phellinus igniarius Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Immune Cell Infiltration in the Spinal Cord.
MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity.
Melanoma complicating treatment with natalizumab for multiple sclerosis.
Retinal architecture and mfERG: Optic nerve head component response characteristics in MS.
Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study.
Dementia in multiple sclerosis: Report of a case with cortical gray matter involvement and frontotemporal-like clinical features.
The effect of intravenous immunoglobulin on neuromyelitis optica.
Multidisciplinary team care in rehabilitation: On overview of reviews.
Oligoclonal bands predict multiple sclerosis in children with optic neuritis.
The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ): development of a shortened scale.
Idiopathic inflammatory demyelinating diseases of the central nervous system in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors and survival.
Tonic spasms are a common clinical manifestation in patients with neuromyelitis optica.
Atomic structures of amyloid cross-beta spines reveal varied steric zippers.
Aquaporins: important but elusive drug targets.
Pages
« first
‹ previous
…
242
243
244
245
246
247
248
249
250
…
next ›
last »